The 9th Annual Pain & Migraine Therapeutics Summit 2015 covers topics such as:
- Analysis of new drug discovery targets
- Review and analysis of key developmental stage therapies for nociceptive pain, neuropathic pain, migraine, back pain, fibromyalgia, cancer pain, arthritic pain, acute pain and chronic pain
- Real-time fMRI (functional magnetic resonance imaging) for pain
- Analysis and case studies of successful commercialization strategies for pain therapies
- Genome-wide association studies of pain
- Challenges of pain clinical trials
- Analysis of NGF antagonist clinical development programs
- Endpoints in pain clinical trials
- Abuse-resistant opioids in clinical development
- Molecular tools for dissecting pain pathways
- The future role of pharmacogenomics, biomarkers and translational research in the development of therapeutics for pain
- Sodium and calcium channel blockers in pre-clinical & clinical development
- Gene therapy for pain
- Clinical development status of longer-acting analgesics for post-operative pain
- Exploration and analysis of animal models for pain
The 9th Annual Pain & Migraine Therapeutics Summit 2015 brings together:
- Chief Scientific Officers, Scientists, Research Fellows, Professors, Chief Executive Officers, Research Directors and Chief Medical Officers
- Directors, Managers, VPs, Associates and Heads from the areas of: Drug development, New Product Planning, Pain research, Neuroscience clinical development, Pain management, Clinical development/research, Scientific Affairs, Drug delivery, Research, Pain management devices, Business development/licensing, Neuroscience drug discovery and Alliance management
- Academic institutions, Investment banks and venture capitalist firms and Consultancies
